UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
BRC Group Holdings
RILY
$289M
| $536K | ﹤0.01% |
15,681
-4,016
| -20% | -$168K |
|
|
GLDD
2102
DELISTED
Great Lakes Dredge & Dock
GLDD
| $535K | ﹤0.01% |
89,863
+10,644
| +13% | +$74.8K |
|
2103
Select Water Solutions
WTTR
$2.61B
| $534K | ﹤0.01% |
57,846
+5,927
| +11% | +$49.9K |
|
2104
First Advantage
FA
$4.12B
| $534K | ﹤0.01% |
41,055
| – | – |
|
2105
Gorman-Rupp
GRC
$2.21B
| $532K | ﹤0.01% |
20,756
| – | – |
|
2106
DocGo
DCGO
$62.6M
| $531K | ﹤0.01% |
75,049
+10,977
| +17% | +$92.1K |
|
2107
Johnson Outdoors
JOUT
$505M
| $529K | ﹤0.01% |
7,997
+3,697
| +86% | +$208K |
|
|
GOOD
2108
Gladstone Commercial Corp
GOOD
$627M
| $527K | ﹤0.01% |
28,507
+6,304
| +28% | +$112K |
|
2109
Stagwell
STGW
$2.24B
| $524K | ﹤0.01% |
84,371
+2,709
| +3% | +$19.5K |
|
|
CLDT
2110
Chatham Lodging
CLDT
$586M
| $523K | ﹤0.01% |
42,619
| – | – |
|
|
BZUN
2111
Baozun
BZUN
$172M
| $523K | ﹤0.01% |
+98,641
| New | +$472K |
|
2112
G-III Apparel Group
GIII
$1.5B
| $520K | ﹤0.01% |
37,959
| – | – |
|
|
WE
2113
DELISTED
WeWork Inc.
WE
| $518K | ﹤0.01% |
9,060
| – | – |
|
2114
Rocket Lab Corp
RKLB
$51.8B
| $516K | ﹤0.01% |
136,772
+3,114
| +2% | +$13.6K |
|
2115
Interface
TILE
$2.22B
| $515K | ﹤0.01% |
52,219
| – | – |
|
2116
Metropolitan Bank Holding Corp
MCB
$1.15B
| $514K | ﹤0.01% |
8,759
| – | – |
|
2117
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $513K | ﹤0.01% |
15,697
+8,276
| +112% | +$262K |
|
2118
Procept Biorobotics
PRCT
$1.17B
| $512K | ﹤0.01% |
+12,328
| New | +$529K |
|
|
CHUY
2119
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $512K | ﹤0.01% |
18,081
+3,730
| +26% | +$108K |
|
2120
SIGA Technologies
SIGA
$219M
| $506K | ﹤0.01% |
68,740
| – | – |
|
2121
OraSure Technologies
OSUR
$279M
| $504K | ﹤0.01% |
104,472
+3,119
| +3% | +$14.3K |
|
|
SLGC
2122
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $502K | ﹤0.01% |
200,001
+101,683
| +103% | +$284K |
|
|
VTYX
2123
DELISTED
Ventyx Biosciences
VTYX
| $502K | ﹤0.01% |
+15,300
| New | +$453K |
|
|
NVTA
2124
DELISTED
Invitae Corporation
NVTA
| $499K | ﹤0.01% |
268,529
| – | – |
|
2125
Arcutis Biotherapeutics
ARQT
$3.18B
| $499K | ﹤0.01% |
33,716
+14,616
| +77% | +$255K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.